As rates rose, "cash-like" ETFs finally started providing a modest yield without the drama of the stock market. Review Summary: Was 2018 a good year to buy? 2018 Context Long-term Verdict Broad Market (VOO/VTI) Rough end to the year (-4% approx).
As of , we can evaluate these 2018 picks with the benefit of hindsight to see which ones stood the test of time. Top ETF Categories of 2018
If you had bought the in 2018, you would have captured the beginning of the massive run-up in Big Tech (Apple, Microsoft, Amazon) that defined the early 2020s. best etf to buy 2018
2018 was a volatile year for the market, characterized by trade tensions and rising interest rates. The "best" ETFs that year generally fell into three categories:
Healthcare often acts as a "defensive" sector during volatility. In 2018, breakthroughs in gene therapy boosted specific biotech ETFs. iShares Nasdaq Biotechnology ETF (IBB) As rates rose, "cash-like" ETFs finally started providing
Are you looking to compare these against current 2026 market leaders , or are you researching for a specific long-term portfolio analysis?
Buying the 2018 dip led to massive gains in 2019-2021. Tech (QQQ) Volatile, but stayed flat/positive. Winner. The dominant theme of the last decade. Dividends (VYM) Struggled due to rising rates. Moderate. Better for income than raw growth. The "Best" Pick in Hindsight As of , we can evaluate these 2018
This remains a foundational tech ETF, though it now faces stiff competition from more specialized AI-focused funds. 2. Healthcare & Biotech (The Defensive Play)